{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:42:06Z","timestamp":1789911726121,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ramathibodi Foundation Children Cancer Fund Under Patronage of HRH Princess Som Sawali Ramathibodi Comprehensive Cancer Center and Faculty of Medicine Ramathibodi Hospital","award":["CF_61004"],"award-info":[{"award-number":["CF_61004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Capillary blood has been increasingly used in point-of-care setting for clinical monitoring in immunology and infectious diseases. We explored whether percentages of lymphocyte subsets (T-cells; CD3+, helper T-cells; CD4+, cytotoxic T-cells; CD8+, B-cells; CD19+, NK cells; CD56+, gamma delta T-cells, and regulatory T-cells) with regard to total lymphocyte count from capillary and venous blood of healthy volunteers were in good agreement.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All percentages of lymphocyte subsets with regard to total lymphocyte count from capillary blood were significantly correlated with those from venous blood (r\u2009\u2265\u20090.9 for every cell type). However, Bland\u2013Altman plots showed high agreement between capillary and venous samples only in those of CD3+, CD4+, and CD8+ cells (limit of agreement percentages from mean venous blood\u2009&lt;\u200920%). However, the agreement of percentages of other lymphocyte subsets from venous and capillary blood was mediocre. We concluded that capillary blood could be used as an alternative for venous blood to determine percentages of CD3+, CD4+, and CD8+ cells with regard to total lymphocyte count.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13104-019-4659-4","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T05:12:51Z","timestamp":1569474771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Capillary blood as an alternative specimen for enumeration of percentages of lymphocyte subsets"],"prefix":"10.1186","volume":"12","author":[{"given":"Supanart","family":"Srisala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nutkridta","family":"Pongsakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiantip","family":"Sahakijpicharn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suradej","family":"Hongeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somchai","family":"Chutipongtanate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1833-5127","authenticated-orcid":false,"given":"Nopporn","family":"Apiwattanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,26]]},"reference":[{"key":"4659_CR1","unstructured":"Abdallah KO, Prak ET. B cell monitoring of transplant patients treated with anti-CD20. Clin Transpl. 2006:427\u201337."},{"key":"4659_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/cpt.621","volume":"102","author":"RL Hoare","year":"2017","unstructured":"Hoare RL, Veys P, Klein N, Callard R, Standing JF. Predicting CD4 T-cell reconstitution following pediatric hematopoietic stem cell transplantation. Clin Pharmacol Ther. 2017;102:349\u201357.","journal-title":"Clin Pharmacol Ther"},{"key":"4659_CR3","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1001\/jama.286.20.2568","volume":"286","author":"RS Hogg","year":"2001","unstructured":"Hogg RS, Yip B, Chan KJ, et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA. 2001;286:2568\u201377.","journal-title":"JAMA"},{"key":"4659_CR4","first-page":"1120","volume":"60","author":"MJ Siedner","year":"2015","unstructured":"Siedner MJ, Ng CK, Bassett IV, Katz IT, Bangsberg DR, Tsai AC. Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002\u20132013: a meta-analysis. Clin Infect Dis. 2015;60:1120\u20137.","journal-title":"Clin Infect Dis"},{"key":"4659_CR5","doi-asserted-by":"publisher","first-page":"d6792","DOI":"10.1136\/bmj.d6792","volume":"343","author":"J Mermin","year":"2011","unstructured":"Mermin J, Ekwaru JP, Were W, et al. Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial. BMJ. 2011;343:d6792.","journal-title":"BMJ"},{"key":"4659_CR6","first-page":"155","volume":"35","author":"A St John","year":"2014","unstructured":"St John A, Price CP. Existing and emerging technologies for point-of-care testing. Clin Biochem Rev. 2014;35:155\u201367.","journal-title":"Clin Biochem Rev"},{"key":"4659_CR7","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/jcp.48.12.1137","volume":"48","author":"SE Cracknell","year":"1995","unstructured":"Cracknell SE, Hinchliffe RF, Lilleyman JS. Lymphocyte subset counts in skin puncture and venous blood compared. J Clin Pathol. 1995;48:1137\u20138.","journal-title":"J Clin Pathol"},{"key":"4659_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1046\/j.1365-2257.2001.00388.x","volume":"23","author":"ZW Yang","year":"2001","unstructured":"Yang ZW, Yang SH, Chen L, Qu J, Zhu J, Tang Z. Comparison of blood counts in venous, fingertip and arterial blood and their measurement variation. Clin Lab Haematol. 2001;23:155\u20139.","journal-title":"Clin Lab Haematol"},{"key":"4659_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11926-016-0616-6","volume":"18","author":"S Giang","year":"2016","unstructured":"Giang S, La Cava A. Regulatory T cells in SLE: biology and use in treatment. Curr Rheumatol Rep. 2016;18:67.","journal-title":"Curr Rheumatol Rep"},{"key":"4659_CR10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/eji.201344280","volume":"45","author":"K Ohl","year":"2015","unstructured":"Ohl K, Tenbrock K. Regulatory T cells in systemic lupus erythematosus. Eur J Immunol. 2015;45:344\u201355.","journal-title":"Eur J Immunol"},{"key":"4659_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5847\/wjem.j.1920-8642.2015.01.001","volume":"6","author":"C Cao","year":"2015","unstructured":"Cao C, Ma T, Chai YF, Shou ST. The role of regulatory T cells in immune dysfunction during sepsis. World J Emerg Med. 2015;6:5\u20139.","journal-title":"World J Emerg Med"},{"key":"4659_CR12","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1128\/CVI.00752-12","volume":"20","author":"JC Andreu-Ballester","year":"2013","unstructured":"Andreu-Ballester JC, Tormo-Calandin C, Garcia-Ballesteros C, et al. Association of gammadelta T cells with disease severity and mortality in septic patients. Clin Vaccine Immunol. 2013;20:738\u201346.","journal-title":"Clin Vaccine Immunol"},{"key":"4659_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.bbmt.2014.09.027","volume":"21","author":"R Perko","year":"2015","unstructured":"Perko R, Kang G, Sunkara A, Leung W, Thomas PG, Dallas MH. Gamma delta T cell reconstitution is associated with fewer infections and improved event-free survival after hematopoietic stem cell transplantation for pediatric leukemia. Biol Blood Marrow Transplant. 2015;21:130\u20136.","journal-title":"Biol Blood Marrow Transplant"},{"key":"4659_CR14","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1097\/01.CCM.0000189745.66585.AE","volume":"33","author":"F Venet","year":"2005","unstructured":"Venet F, Bohe J, Debard AL, Bienvenu J, Lepape A, Monneret G. Both percentage of gammadelta T lymphocytes and CD3 expression are reduced during septic shock. Crit Care Med. 2005;33:2836\u201340.","journal-title":"Crit Care Med"},{"key":"4659_CR15","first-page":"382","volume":"102","author":"R Lertbunrian","year":"2019","unstructured":"Lertbunrian R, Chonpaisan K, Srisala S, Anurathapan U, Apiwattanakul N. Decrease in gamma delta T-cell with microbiologically proven infection in septic oncologic children. J Med Assoc Thai. 2019;102:382\u20139.","journal-title":"J Med Assoc Thai"},{"key":"4659_CR16","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"1","author":"JM Bland","year":"1986","unstructured":"Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307\u201310.","journal-title":"Lancet"},{"key":"4659_CR17","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1097\/QAD.0b013e32823bcb03","volume":"21","author":"CA MacLennan","year":"2007","unstructured":"MacLennan CA, van Oosterhout JJ, White SA, Drayson MT, Zijlstra EE, Molyneux ME. Finger-prick blood samples can be used interchangeably with venous samples for CD4 cell counting indicating their potential for use in CD4 rapid tests. AIDS. 2007;21:1643\u20135.","journal-title":"AIDS"},{"key":"4659_CR18","doi-asserted-by":"publisher","first-page":"e43702","DOI":"10.1371\/journal.pone.0043702","volume":"7","author":"VS Hollis","year":"2012","unstructured":"Hollis VS, Holloway JA, Harris S, Spencer D, van Berkel C, Morgan H. Comparison of venous and capillary differential leukocyte counts using a standard hematology analyzer and a novel microfluidic impedance cytometer. PLoS ONE. 2012;7:e43702.","journal-title":"PLoS ONE"},{"key":"4659_CR19","unstructured":"Medicare, Medicaid and CLIA programs; regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA)-HCFA. Final rule with comment period. Fed Regist. 1992;57:7002\u2013186."},{"key":"4659_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jim.2011.07.008","volume":"372","author":"N Sitoe","year":"2011","unstructured":"Sitoe N, Luecke E, Tembe N, et al. Absolute and percent CD4+ T-cell enumeration by flow cytometry using capillary blood. J Immunol Methods. 2011;372:1\u20136.","journal-title":"J Immunol Methods"},{"key":"4659_CR21","first-page":"723","volume":"48","author":"LN Daae","year":"1988","unstructured":"Daae LN, Halvorsen S, Mathisen PM, Mironska K. A comparison between haematological parameters in \u2018capillary\u2019 and venous blood from healthy adults. Scand J Clin Lab Invest. 1988;48:723\u20136.","journal-title":"Scand J Clin Lab Invest"},{"key":"4659_CR22","doi-asserted-by":"publisher","first-page":"88S","DOI":"10.1038\/jid.1989.16","volume":"93","author":"DE Cavender","year":"1989","unstructured":"Cavender DE. Lymphocyte adhesion to endothelial cells in vitro: models for the study of normal lymphocyte recirculation and lymphocyte emigration into chronic inflammatory lesions. J Invest Dermatol. 1989;93:88S\u201395S.","journal-title":"J Invest Dermatol"},{"key":"4659_CR23","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1097\/QAD.0b013e328344f424","volume":"25","author":"IV Jani","year":"2011","unstructured":"Jani IV, Sitoe NE, Chongo PL, et al. Accurate CD4 T-cell enumeration and antiretroviral drug toxicity monitoring in primary healthcare clinics using point-of-care testing. AIDS. 2011;25:807\u201312.","journal-title":"AIDS"},{"key":"4659_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/QAI.0b013e3181e93071","volume":"55","author":"S Mtapuri-Zinyowera","year":"2010","unstructured":"Mtapuri-Zinyowera S, Chideme M, Mangwanya D, et al. Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe. J Acquir Immune Defic Syndr. 2010;55:1\u20137.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4659_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-1-4939-2172-0_10","volume":"1256","author":"J Balsam","year":"2015","unstructured":"Balsam J, Bruck HA, Rasooly A. Mobile flow cytometer for mHealth. Methods Mol Biol. 2015;1256:139\u201353.","journal-title":"Methods Mol Biol"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-019-4659-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13104-019-4659-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-019-4659-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T23:11:45Z","timestamp":1600989105000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-019-4659-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,26]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4659"],"URL":"https:\/\/doi.org\/10.1186\/s13104-019-4659-4","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,26]]},"assertion":[{"value":"15 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study protocol was approved by the Research Ethical Committee of Ramathibodi Hospital, Mahidol University (ID 09-59-23), and subjects provided written informed consents.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"633"}}